RECRUITING

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.

Official Title

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

Quick Facts

Study Start:2024-01-17
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06225583

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Positive diagnosis of sacroiliac pain or lumbosacral facet arthritis pain
  2. * Age ≥ 18 years
  3. * Positive diagnosis of Bertolotti's Syndrome
  4. * Age ≥ 18 years
  5. * Positive imaging for Bertolotti's Syndrome
  6. * Previous analgesic injection results
  1. * History of spinal deformity, previous spinal surgeries, spinal infections
  2. * Pregnant women
  3. * History of spinal deformity, previous spinal surgeries, spinal infections
  4. * Pregnant women

Contacts and Locations

Study Contact

nya robinson
CONTACT
216-445-1741
robinsn8@ccf.org
Claudia Tellman
CONTACT
216-444-3026
tellmac@ccf.org

Principal Investigator

Michael Steinmetz, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

  • Michael Steinmetz, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-17
Study Completion Date2026-12

Study Record Updates

Study Start Date2024-01-17
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Bertolotti's Syndrome
  • Lower Back Pain